中文版正在生成中，先为你展示英文版分析。
AI核心结论
ABT delivered 7.8% revenue growth to $11.16B in Q1 FY2026, but net income fell 18.7% to $1.08B as a 22.2% surge in SG&A expenses and a 132.7% jump in long-term debt—likely tied to a major acquisition—weighed heavily on profitability and the balance sheet.
营业收入
$11.16B
同比 ++7.78%
每股收益（基本）
$0.62
同比 -18.42%
营业利润
$1.34B
同比 -20.56%
提交于 · 解读更新于 · 来源: SEC EDGAR 10-Q 原文
Abbott Laboratories (ABT) Q1 FY2026 营收 $11.16B，同比增长 7.8%。 净利润 $1.08B，同比下降 18.7%，稀释每股收益 $0.61。
ABT grew total revenue 7.8% year-over-year to $11.16B in Q1 FY2026, up from $10.36B in the prior-year period, indicating continued demand across its business segments despite macroeconomic headwinds.
来源: Source: 10-Q Income Statement
SG&A expenses jumped 22.2% year-over-year to $3.74B from $3.06B, far outpacing revenue growth and contributing to a 20.6% decline in operating income to $1.35B from $1.69B. This cost inflation significantly compressed the operating margin from 16.3% to 12.0%.
来源: Source: 10-Q Income Statement
Total assets surged 35.6% to $110.43B from $81.45B, while long-term debt more than doubled (+132.7%) to $29.64B from $12.74B. Investing cash outflows of -$20.32B versus -$470M in the prior year strongly suggest a large acquisition was completed during the quarter.
来源: Source: 10-Q Balance Sheet & Cash Flow Statement
Financing cash flows swung to +$17.31B from -$2.06B in the prior year, reflecting significant new debt issuance to fund the apparent acquisition, partially offset by reduced share buybacks of $180M versus $280M in the prior-year period.
来源: Source: 10-Q Cash Flow Statement
R&D spending increased 7.1% to $767M from $716M, keeping pace with revenue growth and signaling ABT's continued commitment to innovation even amid elevated SG&A and integration-related costs.
来源: Source: 10-Q Income Statement
Long-term debt surged 132.7% to $29.64B, dramatically increasing ABT's financial leverage. Integration of a large acquisition introduces execution risk, potential goodwill impairment, and elevated interest expense that could further pressure net income in coming quarters.
来源: Source: 10-Q Balance Sheet & Cash Flow Statement
SG&A expenses grew 22.2% to $3.74B, more than double the rate of revenue growth, compressing operating margin by approximately 430 basis points to 12.0%. If these elevated costs persist, sustained margin recovery will be challenging.
来源: Source: 10-Q Income Statement
Current liabilities rose 41.3% to $18.38B, outpacing current asset growth of 10.2%, resulting in a current ratio of 1.39. While still above 1.0, the deterioration in the current ratio signals tighter near-term liquidity relative to the prior year.
来源: Source: 10-Q Balance Sheet
Operating cash flow fell 7.2% to $1.32B from $1.42B, even as revenues grew, suggesting that working capital demands or one-time costs are absorbing cash generation. Sustained declines could limit ABT's ability to service its significantly higher debt load.
来源: Source: 10-Q Cash Flow Statement
Cost of revenue grew 9.4% versus revenue growth of 7.8%, indicating modest gross margin compression. If input cost pressures or acquisition-related cost of goods sold continue to rise faster than revenue, gross profitability will erode further.
来源: Source: 10-Q Income Statement
Q1 FY2026 实际 EPS $1.15，分析师一致预期 $1.16，不及预期 -0.5%。
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业收入 | $11.16B | $10.36B | +7.78% |
营业成本 | $4.89B | $4.47B | +9.44% |
营业利润 | $1.34B | $1.69B | -20.56% |
净利润 | $1.08B | $1.32B | -18.72% |
每股收益（基本） | $0.62 | $0.76 | -18.42% |
每股收益（稀释） | $0.61 | $0.76 | -19.74% |
研发费用 | $767M | $716M | +7.12% |
销售及管理费用 | $3.74B | $3.06B | +22.18% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
总资产 | $110.43B | $81.45B | +35.58% |
流动资产 | $25.51B | $23.15B | +10.17% |
流动负债 | $18.38B | $13B | +41.32% |
股东权益 | $52.06B | $48.81B | +6.66% |
现金及等价物 | $6.8B | $6.53B | +4.15% |
长期债务 | $29.64B | $12.74B | +132.71% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
经营活动现金流 | $1.31B | $1.42B | -7.20% |
投资活动现金流 | $-20.32B | $-470M | -4224.26% |
筹资活动现金流 | $17.31B | $-2.06B | +942.48% |
股票回购 | $180M | $280M | -35.71% |
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营业利润率 | 12.0% | 16.3% | -4.30% |
净利率 | 9.6% | — | — |
净资产收益率 | 2.1% | — | — |
总资产收益率 | 1.0% | — | — |
流动比率 | $1.388 | — | — |
ABT reported Q1 FY2026 revenue of $11.16B, up 7.8% year-over-year, but net income fell 18.7% to $1.08B and diluted EPS dropped to $0.61 from $0.76. The earnings decline was primarily driven by a 22.2% surge in SG&A expenses and the financial impact of what appears to be a major acquisition completed during the quarter.
ABT's operating income fell 20.6% to $1.35B because SG&A expenses surged 22.2% to $3.74B, far outpacing the 7.8% revenue growth. Additionally, the company's long-term debt more than doubled to $29.64B, which likely generated higher interest expense that further reduced net income to $1.08B.
The financial data strongly suggests ABT completed a significant acquisition in Q1 FY2026, as investing cash outflows ballooned to -$20.32B from just -$470M in the prior year. This was funded by new debt issuance, with long-term debt surging 132.7% to $29.64B and total assets jumping 35.6% to $110.43B.
The most significant risks are the integration of what appears to be a large acquisition and the dramatically higher debt burden, with long-term debt up 132.7% to $29.64B. Additionally, SG&A cost inflation at 22.2% growth is compressing margins, with operating margin falling from 16.3% to 12.0%, and current liabilities rose 41.3%, tightening near-term liquidity.
ABT's near-term financial health shows some strain: the current ratio stands at 1.39, operating cash flow declined 7.2% to $1.32B, and leverage has increased substantially with long-term debt more than doubling to $29.64B. However, the company maintains $6.80B in cash and continues to generate positive operating cash flow, suggesting it can service its obligations in the near term.